Search for: "Hyman Phelps McNamara" Results 21 - 40 of 211
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
HP&M Recognized by Best Law Firms® as National Tier 1 – FDA Law and Regional Washington, DC Tier 1 – FDA Law (2024 Edition)
15 Nov 2023, 1:57 am by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Join Us for ACI’s Advanced Legal Regulatory and Compliance Forum on OTC Drugs
13 Nov 2023, 3:15 am by Hyman Phelps McNamara
 Program highlights include: Spotlight on FDA’s Newly Proposed ACNU Rule Updates on Monograph Reform Implementation Advertising, Labeling and Claims Substantiation Essentials Exploring the Recent Wave of Rx-OTC Drug Switches Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Hyman, Phelps & McNamara, P.C. Takes Top Honors in Two Prestigious Categories in 2023 LMG Life Sciences Awards
6 Nov 2023, 4:51 pm by Hyman Phelps McNamara
About Hyman, Phelps & McNamara Hyman, Phelps & McNamara, P.C. is the largest dedicated food and drug law firm in the country. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
14th Asia Pacific Symposium on Cochlear Implant and Related Sciences Set to Convene in Seoul — Featuring HP&M’s Dr. Philip Won
5 Nov 2023, 7:32 pm by Hyman Phelps McNamara
Philip Won, of Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Senior FDA Official Dr. Julie Beitz Joins Hyman, Phelps & McNamara, P.C. as Principal Drug Regulatory Expert
10 Oct 2023, 8:46 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Clinical Trial Diversity: Understanding the Effects of the New Federal Guidelines on Your Clinical Trials
28 Sep 2023, 10:14 pm by Hyman Phelps McNamara
On October 11th, Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Reminder: HP&M Webinar on Recent Hospital Controlled Substance Diversion Cases — Cautionary Tales; Tuesday, October 3, 2023: 12:00-12:45
26 Sep 2023, 2:23 am by Hyman Phelps McNamara
  Non-compliant facilities face: Increased patient and employee health risks — in some cases even overdose deaths Multi-million-dollar settlements — and these amounts have been increasing each year Significant long-term compliance costs to meet the requirements of government settlement agreements Erosion of public trust and confidence in affected hospitals and pharmacies Unwanted local and national publicity Hyman, Phelps & McNamara (HP&M) invites… [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Hyman, Phelps & McNamara, P.C. Names Jeff Grizzel Chief Marketing Officer
26 Sep 2023, 2:23 am by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
HP&M’s Faraz Siddiqui to Speak at Informa’s Medicaid Drug Rebate Program (MDRP) Summit 2023 on Value Based Programs
15 Sep 2023, 3:44 am by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Join Us for an HPM Webinar: Recent Hospital Controlled Substance Diversion Cases — Cautionary Tales; Tuesday, October 3, 2023: 12:00-12:45
12 Sep 2023, 8:28 pm by Hyman Phelps McNamara
  Non-compliant facilities face: Increased patient and employee health risks — in some cases even overdose deaths Multi-million-dollar settlements — and these amounts have been increasing each year Significant long-term compliance costs to meet the requirements of government settlement agreements Erosion of public trust and confidence in affected hospitals and pharmacies Unwanted local and national publicity Hyman, Phelps & McNamara (HPM) invites you… [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Fourteen HP&M Attorneys Recognized by Best Lawyers® in 2024 in America
24 Aug 2023, 6:42 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
HP&M Attorneys Receive Accolades: Top Lawyer Under 40 and WWL: Life Sciences 2023 Global Elite Thought Leader
27 Jun 2023, 2:29 am by Hyman Phelps McNamara
Valentine Named Top Lawyer Under 40; Only Food and Drug Lawyer Selected Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
HP&M to Co-Chair the Host Committee for the IBA World Life Sciences Conference
25 May 2023, 2:25 am by Hyman Phelps McNamara
Hyman Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
REMINDER: HP&M’s Webinar “Demystifying DEA Inspections: Accountability Audits, Mirror Reviews and Mock Inspections”
22 May 2023, 9:52 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Join Us for an HP&M Webinar – Demystifying DEA Inspections: Accountability Audits, Mirror Reviews and Mock Inspections (Wednesday, May 24: 12:00-12:45)
3 May 2023, 2:20 am by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
HPM’s John Claud to host webinar for FDANews: “Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC.”
12 Apr 2023, 5:43 pm by Hyman Phelps McNamara
On Thursday, April 20, from 1:30-3:00pm, John Claud of Hyman, Phelps & McNamara, P.C. will present a webinar entitled “Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
The “End of the COVID-19 Emergency and the Ryan Haight Act: Telemedicine and Next Steps” – Availability of HPM’s Presentation Deck and Recording of the Presentation
27 Mar 2023, 8:45 pm by Hyman Phelps McNamara
Thank you to those who registered for and attended Hyman, Phelps & McNamara’s March 23, 2023 lunchtime webinar addressing the “End of the COVID-19 Emergency and the Ryan Haight Act: Telemedicine and Next Steps. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
HP&M Attorney Mark Tobolowsky Co-Authors Article in Human Gene Therapy Advocating for the Acceptance of Microdystrophin Expression in DMD Patients as a Surrogate Endpoint for Accelerated Approval
19 Mar 2023, 4:38 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Ricardo Carvajal to Moderate Panel at FDLI’s Food and Dietary Supplement Safety and Regulation Conference
15 Mar 2023, 10:08 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
JOIN HP&M FOR A WEBINAR: “The ‘End’ of the COVID-19 Emergency: The Ryan Haight Act, Telemedicine, and Next Steps?” on Thursday, March 23, 2023 at 12 Noon EST
12 Mar 2023, 7:20 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara, P.C. [read post]
FDA Law Blog - https://www.thefdalawblog.com/